Regeneron Pharmaceuticals, Inc. and Society for ... Among 40 Regeneron Contest Finalists appeared first on Tarrytown-Sleepy Hollow Patch.

Shares of NASDAQ:REGN opened at $716.72 on Tuesday. The company has a quick ratio of 4.46, a current ratio of 5.28 and a debt-to-equity ratio of 0.09. Regeneron Pharmaceuticals has a fifty-two ...

Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...

Regeneron Pharmaceuticals had a net margin of 33.61% and a return on equity of 16.88%. The company had revenue of $3.79 billion for the quarter, compared to analyst estimates of $3.76 billion.

The fact that multiple Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors.

Includes reviews of Sleepy Hollow Chrysler Jeep Dodge Ram from DealerRater. Want to share your experience with this dealership? Service got me in the day after I called. Ran tests, confirmed what ...

(RTTNews) - Regeneron Pharmaceuticals (REGN) announced earnings for fourth quarter that decreased from the same period last year but beat the Street estimates. The company's bottom line came in at ...

SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is facing mounting pressure on multiple fronts. Following disappointing sales figures and ongoing ...

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Regeneron Pharmaceuticals. The Motley Fool has a disclosure policy.

STS Scholars await the speakers’ arrival at Regeneron, February 3rd, (left to right): Kelly Deng, Andrew Levy, Anthony Jiang, Haylli Yunga, Isabella Pushpa Vembenil, Vivek Malik. Photo supplied On ...